0,00 €
currency
0

ELMETACIN spray 100ml

50005547

Medicinal preparation

ELMETACIN spray 100ml
-32%
standard price 7,00 €
you save 32%
4,80 €
Total including VAT

Application form: liquids for external use (solutions, sprays, emulsions)

Indication group: nonsteroid antiphlogistics and antirheumatics

Active substance: Indometacinum 8 mg v 1 ml (0,8 g)

minimum amount for dispatch: Elmetacin belongs to the group of medicaments called non-steroidal antirheumatic drugs. Solution of Elmetacin contains anti-flammatory agent called indomethacine. After local administration, the healing substance is absorbed through skin and penetrates into affected regions, where it assuages inflammation, eases pain and reduces oedema. In this way, clinical signs of inflammation are healed locally with insignificant strain to whole organism. Elmetacin is used for external supportive treatment of pain - in the case of acute contusions, sprains or strained muscles of upper and lower extremities as a result of dull injuries, for example at sport - in the case of rheumatic inflammatory diseases of soft tissues, for example tendonitis and peritendinitis In the case of rheumatic diseases of tissues, the preparation can be used only after consultation with doctor. Elmetacin is applied 3-5 times daily. In dependence on the size of painful area, 0.5 – 1.5 ml of Elmetacin solution, e.g. 4 - 13 presses of the spray are necessary for the treatment. Total daily dose should not exceed 7.5 ml of Elmetacin solution, which corresponds to 60 mg of indomethacine.

EAN: 4011548007877 4011548021347

Manufacturer: Stada Arzneimittel AG, Bad Vilbel, Germany, www.stada.de

Parametry
SUKL názevELMETACIN 8MG/ML DRM SPR SOL 1X100ML
SUKL kód0107189

ELMETACIN spr 1x100ml 1%
FLECTOR EP gel 100g
medicinal preparation
Ověření internetových stránek a lékárny:
SUKL
Státní ústav pro kontrolu léčiv, Šrobárova 48, 100 41 Praha 10, www.sukl.cz

Reporting of side effects
© Česká lékárna Holding a.s. All rights reserved.

info  Cookies help us in providing our services. By using our services, you agree to our use of cookies.